Combined Inhibition of Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways in Non–small Cell Lung Cancer Therapy

Combined Inhibition of Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways in Non–small Cell Lung Cancer Therapy

Bibliographic Details
Main Authors:	Qinghua ZHOU, Zhanque ZHANG, Allen C. Gao, Yan DING, Qian LIU, Juan NAN
Format:	Article
Language:	zho
Published:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2009-12-01
Series:	Chinese Journal of Lung Cancer
Subjects:	Lung neoplasms
Online Access:	http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2009.12.20&path[]=1244

Similar Items

The Role of Anti–Epidermal Growth Factor Receptor and Anti-Vascular Endothelial Growth Factor Therapies in the Treatment of Non-Small-Cell Lung Cancer
by: Corey LANGER, et al.
Published: (2010-09-01)

A Review of Epidermal Growth Factor Receptor/HER2 Inhibitors in the Treatment of Patients with Non–Small-Cell Lung Cancer
by: Ramaswamy GOVINDAN
Published: (2010-04-01)

Relationship between Mutations of the Epidermal Growth Factor Receptor Gene and Drug-Resistance to Gefitinib in Human Lung Cancer in vitro
by: Wei WEI, et al.
Published: (2009-01-01)

Expressions and Their Significances of Vascular Endothelial Growth Factor-C mRNA and Epidermal Growth Factor Receptor mRNA in Non-small Cell Lung Cancer Tissues and Lymph Node Tissues
by: Yan GUAN, et al.
Published: (2010-12-01)

Immunotherapy in Epidermal Growth Factor Receptor-mutant  Non-small Cell Lung Cancer
by: Xin WANG, et al.
Published: (2019-08-01)

Epidermal Growth Factor Receptor Mutations and Radiotherapy  in Non-small Cell Lung Cancer
by: Xing ZHONG, et al.
Published: (2013-03-01)

Optimal Therapeutic Strategy for Non-small Cell Lung Cancer with Mutated Epidermal Growth Factor Receptor
by: Zhong SHI, et al.
Published: (2015-02-01)

Advances of Targeted therapies in Non-small Cell Lung Cancer
by: Zhanque ZHANG, et al.
Published: (2009-12-01)

Adequacy of biopsy samples for epidermal growth factor receptor (EGFR) molecular testing in lung adenocarcinoma
by: Tegeltija Dragana, et al.
Published: (2021-01-01)

Protein expression, gene amplification, epidermal growth factor receptor mutations and lung carcinoma
by: Panjković Milana, et al.
Published: (2014-01-01)

Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor  Receptor Mutations in Non-small Cell Lung Cancer
by: Xue YANG, et al.
Published: (2015-08-01)

Research Progress on the Relationship between Insulin-like Growth Factor-I and Lung Cancer
by: Zhe LIU, et al.
Published: (2010-06-01)

Pooled Analysis of the Trials of Erlotinib Monotherapy for Epidermal Growth Factor Receptor (EGFR)-mutant Advanced Non-small Cell Lung Cancer
by: Li MA, et al.
Published: (2009-12-01)

Epidermal growth factor receptor inhibitors in non-small cell lung cancer: current status and future perspectives
by: Mauro Zükin
Published: (2012-04-01)

Retreatment with Epidermal Growth Factor Receptor Inhibitor After Initial Failure in Advanced Non-small Cell Lung Cancer
by: Tongtong AN, et al.
Published: (2011-03-01)

VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
by: Shaney L. Barratt, et al.
Published: (2018-04-01)

Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them
by: Yunshu SHI, et al.
Published: (2019-05-01)

Discordance of Epidermal Growth Factor Receptor Mutations between Primary  and Corresponding Metastatic Tumors in Non-small Cell Lung Cancer
by: Qin FANG, et al.
Published: (2011-06-01)

Association between thyroid cancer and epidermal growth factor receptor mutation in female with nonsmall cell lung cancer
by: Seo Yun Kim, et al.
Published: (2017-01-01)

Molecular Mechanism of Erlotinib Resistance in Epidermal Growth Factor Receptor  Mutant Non-small cell Lung Cancer Cell Line H1650
by: Ruili HAN, et al.
Published: (2012-12-01)

Erlotinib-induced Skin Rash in Patients with Non–small Cell Lung Cancer: Pathogenesis, Clinical Significance and Treatment
by: Qinghua ZHOU, et al.
Published: (2009-12-01)

Analysis of Mutations in Epidermal Growth Factor Receptor Gene in Korean Patients with Non-small Cell Lung Cancer: Summary of a Nationwide Survey
by: Sang Hwa Lee, et al.
Published: (2015-11-01)

Changes in Serum Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9  After Video-assisted Thoracoscopic Surgery and Thoracotomic Lobectomy  in the Treatment of Patients with Non-small Cell Lung Cancer
by: Wenxin TIAN, et al.
Published: (2014-01-01)

Research Progress on Resistance Mechanisms of Epidermal Growth Factor Receptor  Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
by: Yuan LI, et al.
Published: (2012-02-01)

Mechanisms of Resistance to the Third-generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
by: Lianfang NI, et al.
Published: (2018-02-01)

Advances of Tissue Factor in Lung Cancer
by: Chengcheng XU, et al.
Published: (2010-09-01)

Association between the Epidermal Growth Receptor Status and the Efficacy of First-line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer
by: Na QIN, et al.
Published: (2015-03-01)

Vascular endothelial growth factor (VEGF) and prostate pathology
by: Francisco Botelho, et al.
Published: (2010-08-01)

Pay more efforts on lung cancer research, to improve the therapeutic effects of N2 lung cancer
by: Qinghua ZHOU
Published: (2008-10-01)

Application of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor as the First-line Therapy in Patients with Advanced Non-small Cell Lung Cancer
by: Chunsun LI, et al.
Published: (2010-01-01)

Adenocarcinoma of the lung with positive epidermal growth factor receptor mutation in pregnancy
by: Gina Amanda, et al.
Published: (2017-01-01)

Listing in Medline: A New Milestone for the Chinese Journal of Lung Cancer
by: Qinghua ZHOU
Published: (2010-08-01)

Molecular diagnostics and molecular staging of lung cancer
by: Zhihao WU, et al.
Published: (2008-02-01)

Advances of RAF and lung cancer
by: Zhuomin WANG, et al.
Published: (2008-06-01)

Clinical Experience with First-generation Epidermal Growth Factor Receptor  Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients  with Brain Metastasis
by: Huixing DONG, et al.
Published: (2017-02-01)

Progress of surgical therapy for N2 non-small cell lung cancer
by: Qinghua ZHOU
Published: (2008-10-01)

Research Progress of Lung Cancer on Single Nuleotide Polymorphism
by: Feng HUA, et al.
Published: (2011-02-01)

Toward a "tailored" Era for Basic Research and Clinical Therapy of Lung Cancer-A Report of the 12th World Conference on Lung Cancer
by: Qinghua ZHOU, et al.
Published: (2008-02-01)

The Relationship between Nano-quartz Oxidative Damage and the High Expression of Nuclear Factor NF-κB of Lung Cancer in Xuanwei, Yunnan
by: Mengjiao QIAN, et al.
Published: (2009-11-01)

Transcription Factor Snail and Epithelial-Mesenchymal Transition of Tumor
by: Lin LI, et al.
Published: (2011-09-01)